News

Filter

Current filters:

None

8501 to 8510 of 97887 results

Corcept sells capped royalty on future sales for $30 million

09-08-2012

US drug developer Corcept Therapeutics (Nasdaq: CORT) announced that it has sold to an investment fund…

Corcept TherapeuticsFinancialKorlymPharmaceutical

AstraZeneca/BTG abandon CytoFab for sepsis as it fails in Ph IIb

09-08-2012

Anglo-Swedish drug major AstraZeneca (LSE: AZN) has decided to halt any further development of AZD9773…

Antibiotics and Infectious diseasesAstraZenecaBTGCytoFabLicensingPharmaceuticalResearch

EMA approves GlaxoSmithKline's Votrient for soft tissue sarcomas

09-08-2012

UK pharma giant GlaxoSmithKline (LSE: GSK) says that the European Medicines Agency has approved Votrient…

EuropeGlaxoSmithKlineOncologyPharmaceuticalRegulationVotrient

Agennix plunges as talactoferrin fails in NSCLC Ph III trial

09-08-2012

Germany and USA-based drug discover Agennix (FSE: AGX) saw its shares plummet 74% to 0.49 euros after…

AgennixOncologyPharmaceuticalResearchtalactoferrin

Amgen halts ganitumab study on little hope of success

09-08-2012

USA-based Amgen (Nasdaq: AMGN), the world's largest independent biotech firm, late yesterday revealed…

AmgenBiotechnologyganitumabgemcitabine HclOncologyResearch

Novo Nordisk ups forecast on strong diabetes drug sales

09-08-2012

Denmark's Novo Nordisk, the world's largest insulin producer, this morning posted financial results for…

DiabetesFinancialNovo NordiskPharmaceuticalResearch

US FTC issues opinion favoring generics makers' initiative to address drug shortages

09-08-2012

The USA's Federal Trade Commission's Bureau of Competition staff has issued a positive advisory opinion…

GenericsHealthcareLegalNorth America

World's first (official) biosimilar antibody goes to reumatoid arthritis

09-08-2012

The end of July 2012 proved exciting for the world of biosimilar manufacturers. However, for the regulatory…

BiotechnologyCellTrionGenericsGlobalinfliximabJohnson & JohnsonMarkets & MarketingRegulationRemicadeRemsima

New products helping overcome generic competition for Lexapro, says Lundbeck

08-08-2012

Danish CNS drugmaker Lundbeck reported first-half 2012 sales of 7.34 billion Danish kroner ($1.22 billion),…

FinancialLicensingLu AE58054LundbeckPharmaceutical

8501 to 8510 of 97887 results

COMPANY SPOTLIGHT

Menarini

Back to top